Which ELISA Kit targets should you be watching in Neuroscience?
5
Min Read
In this blog:
- Which ELISA kit targets are most cited in neuroscience research?
- Which targets are growing?
- Which companies supply the top products?
CiteAb collects unique, citation-based market data by using patent-protected text mining technology on the scientific literature. This data powers analysis into global research trends.
Which ELISA kit targets are researchers citing most frequently in their neuroscience research? Today we dig into this question to better understand the market.
For suppliers looking to stay ahead with their ELISA kit portfolio and inform better product development programmes, it is critical to unpack trends on a broad, quantitative scale, combined with current methods you may have such as using internal or qualitative data.
What data did we use for this analysis?
Our data collection pipeline combines AI-driven text mining with expert human review, giving a quantitative view of reagent usage in real research.
Our ELISA kit database covers nearly one million products. With citation data from hundreds of suppliers, this data provides a comprehensive view of the market.
For this analysis, we focused only on neuroscience-related publications, ranking ELISA kit targets – combined across species – by their share of citations.
The top ELISA kit targets in neuroscience
Tumour Necrosis Factor took the top spot in 2025 with over 10% of total citation share in neuroscience publications.
This cytokine is critical for immune response in the central nervous system. Its dysregulation has been linked to Alzheimer’s, Parkinsons’, multiple sclerosis and ALS, through mechanisms including neuroinflammation and protein aggregation. This makes it a sustained priority for both basic research and therapeutic development. [1]
TNF citation share has fluctuated year to year, but its dominance has been steady since 2017. Suppliers with strong TNF offerings are serving the core of this market.
Interleukin-6 and Interleukin-1 beta took second and third spot respectively in 2025. Both of these targets have seen an overall positive trend in citation share.
As key mediators of neuroinflammation, their roles in Alzheimer’s disease, neurodevelopmental disorders, and psychiatric conditions and more keep them firmly in the research spotlight.
And they’re not alone – two further interleukins appear in the top ten, reflecting just how central the neuroinflammation axis is to research priorities.
Interestingly, none of the targets in the top ten are seeing significant positive trajectories in citation share. This suggests the rankings are stable for now, but it also leaves the door open for emerging targets to move up as research continues to evolve.
ELISA Kit Targets to Watch
For the next part of our analysis, we asked the question, where is significant growth happening? Signals for forward-looking suppliers may be further down the rankings.
Consistent growth: Triggering Receptor expressed on myeloid cells 2
This target has shown consistent year-over-year growth, growing from near-zero visibility (0.00%) in 2017 to 0.57% in 2025. It currently sits within the top 40, but if it continues to grow we could see this change in the future.
A notable surge: Interleukin-4
Currently the 17th most cited target, Interleukin-4 saw a big surge in 2022 to a share of 0.76%, before peaking in 2024 at 0.90%. Although its share dipped slightly in 2025, its footprint remains significantly larger than in previous years.
Bonus Data: Top ELISA Kit products
Looking beyond targets to individual products, we found that for the top 10 cited ELISA kits in neuroscience research Thermo Scientific was particularly dominant.
Their products held the top three positions – all Amyloid beta detection kits (KHB3441, KHB3481, and KMB3441). This suggests that in Alzheimer’s research specifically, the scientific community has converged on a small set of trusted standards. Two of these products were for Human targets, and one for a Mouse target. Beyond the top three, most of the top ten products were for mouse targets.
Other suppliers with products in the top 10 included R&D Systems, Enzo Life Sciences, and Boster Biological Technology. Download the full breakdown at the bottom of this blog.
Curious to see how your products are ranking? You can learn more about our market data services here.
Wrap-up and data download
Whether you’re planning your strategy, evaluating where to invest in new products, or benchmarking your catalogue against market demand, citation-based intelligence cuts through guesswork.
Below, you can download the citation share of the top 10 ELISA kit targets in neuroscience related publications, as well as the top 10 products, for your own analysis.
If you’re looking for more neuroscience insights, you can check out our blog from last year where we delved into the top 10 antibody targets in neuroscience.
Sign up for data
Something seems to have gone wrong while loading the form.
Drop us a message and we can send you the data directly.
References
[1] https://www.nature.com/nature-index/topics/l4/tumor-necrosis-factor-modulation-in-neurological-disorders
